Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma

por Pandya, Pankita H., Cheng, Lijun, Saadatzadeh, M. Reza, Bijangi-Vishehsaraei, Khadijeh, Tang, Shan, Sinn, Anthony L., Trowbridge, Melissa A., Coy, Kathryn L., Bailey, Barbara J., Young, Courtney N., Ding, Jixin, Dobrota, Erika A., Dyer, Savannah, Elmi, Adily, Thompson, Quinton, Barghi, Farinaz, Shultz, Jeremiah, Albright, Eric A., Shannon, Harlan E., Murray, Mary E., Marshall, Mark S., Ferguson, Michael J., Bertrand, Todd E., Wurtz, L. Daniel, Batra, Sandeep, Li, Lang, Renbarger, Jamie L., Pollok, Karen E.
Publicado en Cancers (Basel) (2020)